These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22410449)

  • 1. Partial trisomy 4q associated with young-onset dopa-responsive parkinsonism.
    Garraux G; Caberg JH; Vanbellinghen JF; Jamar M; Bours V; Moonen G; Dive D
    Arch Neurol; 2012 Mar; 69(3):398-400. PubMed ID: 22410449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family.
    Wider C; Skipper L; Solida A; Brown L; Farrer M; Dickson D; Wszolek ZK; Vingerhoets FJ
    Parkinsonism Relat Disord; 2008 Aug; 14(6):465-70. PubMed ID: 18342564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delay discounting of reward and caudate nucleus volume in individuals with α-synuclein gene duplication before and after the development of Parkinson's disease.
    Szamosi A; Nagy H; Kéri S
    Neurodegener Dis; 2013; 11(2):72-8. PubMed ID: 23038403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.
    Nishioka K; Hayashi S; Farrer MJ; Singleton AB; Yoshino H; Imai H; Kitami T; Sato K; Kuroda R; Tomiyama H; Mizoguchi K; Murata M; Toda T; Imoto I; Inazawa J; Mizuno Y; Hattori N
    Ann Neurol; 2006 Feb; 59(2):298-309. PubMed ID: 16358335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopa-responsive, nonprogressive juvenile parkinsonism: report of a case.
    Rajput A; Kishore A; Snow B; Bolton CF; Rajput AH
    Mov Disord; 1997 May; 12(3):453-6. PubMed ID: 9159748
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic linkage studies in autosomal dominantly inherited L-DOPA responsive parkinsonism. Evaluation of candidate genes.
    Gasser T; Wszolek Z; Supala A; Trofatter J; Ozelius L; Uitti RJ; Pfeiffer RF; Gusella J; Calne D; Breakefield XO
    Adv Neurol; 1996; 69():87-95. PubMed ID: 8615189
    [No Abstract]   [Full Text] [Related]  

  • 7. [Relationship between alpha-synuclein and Parkinson's disease].
    Nishioka K; Hattori N
    Brain Nerve; 2007 Aug; 59(8):825-30. PubMed ID: 17713118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia.
    Ikeuchi T; Kakita A; Shiga A; Kasuga K; Kaneko H; Tan CF; Idezuka J; Wakabayashi K; Onodera O; Iwatsubo T; Nishizawa M; Takahashi H; Ishikawa A
    Arch Neurol; 2008 Apr; 65(4):514-9. PubMed ID: 18413475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal balanced translocation (4;21) leading to an offspring with partial duplication of 4q and 21q without phenotypic manifestations of Down syndrome.
    El-Ruby M; Hemly NA; Zaki MS
    Genet Couns; 2007; 18(2):217-26. PubMed ID: 17710874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy?
    Mercuri NB; Bernardi G
    Trends Pharmacol Sci; 2005 Jul; 26(7):341-4. PubMed ID: 15936832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions.
    Wilcox RA; Churchyard A; Dahl HH; Hutchison WM; Kirby DM; Thyagarajan D
    Mov Disord; 2007 May; 22(7):1020-3. PubMed ID: 17357142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio).
    Stocchi F; Marconi S
    Clin Neuropharmacol; 2010 Jul; 33(4):198-203. PubMed ID: 20414107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary spastic paraplegia associated with dopa-responsive parkinsonism.
    Micheli F; Cersósimo MG; Zúñiga Ramírez C
    Mov Disord; 2006 May; 21(5):716-7. PubMed ID: 16463348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.
    Fuchs J; Nilsson C; Kachergus J; Munz M; Larsson EM; Schüle B; Langston JW; Middleton FA; Ross OA; Hulihan M; Gasser T; Farrer MJ
    Neurology; 2007 Mar; 68(12):916-22. PubMed ID: 17251522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa-responsive parkinsonism associated with hydrocephalus.
    Kim MJ; Chung SJ; Sung YH; Lee MC; Im JH
    Mov Disord; 2006 Aug; 21(8):1279-81. PubMed ID: 16639728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopa Responsive Parkinsonism in an Early Onset Alzheimer's Disease Patient with a Presenilin 1 Mutation (A434T).
    Jo H; Kim M; Park S; Park JE; Cho SH; Kim SJ; Jang H; Jung YH; Kim J; Na DL; Seo SW; Cho JW; Kim HJ
    J Alzheimers Dis; 2019; 71(1):7-13. PubMed ID: 31322578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Young-onset Parkinson's disease revisited--clinical features, natural history, and mortality.
    Schrag A; Ben-Shlomo Y; Brown R; Marsden CD; Quinn N
    Mov Disord; 1998 Nov; 13(6):885-94. PubMed ID: 9827611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Controversial issues concerning the initial treatment of Parkinson's disease: L-Dopa or dopaminergic agonists?].
    Defer GL
    Rev Neurol (Paris); 1999 Jan; 155(1):43-5. PubMed ID: 10093847
    [No Abstract]   [Full Text] [Related]  

  • 19. Autosomal recessive juvenile Parkinson's disease with partial trisomy of chromosome 6q syndrome: a case report.
    Namihira T; Hattori N; Shiroma S; Miyazato Y
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):672-3. PubMed ID: 15601396
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment and prognosis of juvenile parkinsonism--L-dopa responsiveness].
    Takubo H
    Nihon Rinsho; 1997 Jan; 55(1):101-5. PubMed ID: 9014430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.